Completely agree mate, although I think the company didn't have much choice but to announce something regarding GSK, because we had alot of information about it before and we knew it was regarding non-powered oral care with GSK etc etc,
I was more referring to all of these products with P&G that we have no idea about (i.e products 2 to 8), if we don't keep track of how much products are "under evaluation" vs "under development" vs "in clinical evaluations" then plenty of products that are "under evaluation" or "under development" can come and go from the list and we would be none the wiser... I *think* that is what may have caused some of the discrepancies between some of the announcements/broker blog posts etc (i.e 3, 4, 5 products under development)
- Forums
- ASX - By Stock
- WFL
- oracle puts it out there.....
oracle puts it out there....., page-70
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online